Lizhi
Back to libraryEntry · LZH-015
ACTH(4-7) analog · Neurocognitive research

Semax

Stabilized ACTH(4-7) analog

Technical datasheetLZH-015
Code
ACTH(4-7) analog
Half-life
Short plasma; central activity hours
Research route
Intranasal (research)
Molecular targets
BDNF / NGF upregulation · monoamine modulation
Discovery / disclosure
Institute of Molecular Genetics, Moscow, 1980s
Target purity
≥ 98%
Recommended storage
−20°C, light protected. 2 to 8°C after reconstitution.
Aliases
ACTH(4-7) PGP analog
Appearance
White lyophilized powder
Solubility
Water soluble
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Analysts reviewing the HPLC chromatogram for the current batch
FIG. 201Analytical Lab

Identity, purity and main-peak area are checked by reversed-phase HPLC against an in-house reference standard for this sequence. The chromatogram you see on the certificate of analysis is generated at this exact bench, by the analysts who release the batch.

Technician monitoring a stainless steel reactor during scale-up
FIG. 202Scale-up Operations

When a sequence moves from milligram research lots to multi-gram research supply, the same chemistry is transferred onto jacketed stainless reactors. Temperature, agitation and reagent equivalents are logged in real time so that the larger batch matches the analytical fingerprint of the small one.

01

Overview

Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence with a C-terminal Pro-Gly-Pro extension improving stability.

02

Pharmacology and mechanism

Upregulates BDNF and neurotrophin expression, modulates central monoamines and influences neural plasticity.

03

Research areas

R.01
Stabilized ACTH(4-7) analog

Classical tool peptide in ischemic brain injury, attention and learning memory studies.

04

Structural notes

Heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro.

Sequence
Met-Glu-His-Phe-Pro-Gly-Pro
For research use only. Not medical advice. Not for diagnosis or treatment.